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“Sudden death is more common in those who are naturally
fat than in the lean.”
—Hippocrates (1)
Clearly, obesity is a problem that is reaching epidemic
proportions in the U.S., with nearly 70% of adults being
classified as overweight or obese compared with fewer than
25% 40 years ago (2,3). Although too often obesity is viewed
as a cosmetic problem as opposed to a major health concern,
there is no question that obesity places a “heavy” burden on
the entire cardiovascular system, contributing to consider-
able overall morbidity and mortality, a fact that was even
recognized by Hippocrates centuries ago. In fact, recent
evidence indicates that obesity is associated with more
morbidity than smoking, alcoholism, and poverty, and if
current trends continue will account for over 300,000 deaths
annually in the U.S., thus overtaking cigarette abuse as the
leading preventable cause of death (2,4,5).
CORONARY RISK
Obesity has adverse effects on several coronary artery disease
(CAD) risk factors. Obese patients are more likely to be
hypertensive than lean patients, and weight gain is typically
associated with increases in arterial pressure (6). However,
independent of arterial pressure, obesity increases the risk of
left ventricular hypertrophy (LVH), particularly of the
eccentric type (7,8). Obesity also adversely affects plasma
lipids, especially increasing triglycerides and decreasing the
cardioprotective levels of high-density lipoprotein choles-
terol, and is the major contributor to adult-onset diabetes
mellitus and the insulin resistance syndrome (now
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called metabolic syndrome), which are associated with high
levels of inflammation and overall cardiovascular mortality
(9–12). Despite adversely affecting these risk factors, in-
cluding markedly increasing levels of high sensitivity
C-reactive protein (12), data from both the Framingham
Heart Study (13) and a large cohort of U.S. nurses (14) have
indicated that obesity is an independent risk factor for major
CAD events in men and, particularly, in women.
CARDIAC FUNCTION
In addition to increasing eccentric LVH and the propensity
for more complex dysrhythmias (4,5,15–18), obesity also
has adverse effects on cardiac function. Diastolic abnormal-
ities occur with all types of LVH (16), with the most
marked abnormalities occurring in those with both obesity
and hypertension, especially in those with left atrial abnor-
mality by electrocardiogram (19). Although preload depen-
dent indices of systolic function (e.g., ejection fraction)
remain preserved early in obesity, preload independent
indices (e.g., end-systolic stress/end-systolic volume index)
demonstrate reduced contractility early in obesity (20).
Alpert et al. (21–23) have confirmed the adverse effects of
significant obesity on both diastolic and systolic ventricular
function. In a study of 74 morbidly obese patients, Alpert et
al. (21) demonstrated that nearly one-third had clinical
evidence of heart failure (HF), and the probability of HF
increased with increasing duration of morbid obesity. At 20
and 25 years of obesity duration, the probability of HF was
66% and 93%, respectively. A recent epidemiologic study
from the Framingham Heart Study indicates that over-
weightness and obesity are potent predictors of subsequent
clinical HF (24).
WEIGHT REDUCTION
Recognizing the adverse effects of obesity, weight reduction
has been shown to produce numerous cardiovascular bene-
fits, including reducing arterial pressure, preload, afterload,
sympathetic stimulation to the cardiovascular system, and
LVH (4,5,25). Alpert et al. (21) demonstrated that New
York Heart Association (NYHA) functional class improved
in 12 of 14 morbidly obese patients who achieved marked
weight loss (30% of total weight) after gastroplasty—by
an average of at least one functional class. Weight loss was
also associated with marked improvements in left ventricular
(LV) chamber size, LV end-systolic wall stress, and diastolic
and systolic ventricular function in these patients. In our
cardiac rehabilitation program for patients with CAD,
where nearly 40% met criteria for obesity, even small
reductions in body weight (e.g., 5% or average 10%) were
associated with marked improvements in obesity indices,
lipids, and exercise capacity compared with obese patients
who did not lose weight (9).
HEART FAILURE PROGNOSIS
Although obesity is clearly associated with more cardiovas-
cular disease, and several studies indicate a progressive
increase in all-cause mortality and years of life lost associ-
ated with overweightness and, especially, with obesity (26),
recent studies have focused on an apparent paradox regard-
ing the relationship between obesity and subsequent cardio-
vascular prognosis. For example, in a group of patients with
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severe systolic HF, we recently demonstrated a strong inverse
relationship between indices of obesity and body composition,
including percent body fat and total body fat, as well as body
mass indices (BMI), and subsequent clinical prognosis (27).
Clearly, in advanced HF, cachexia and wasting appear to be
independent predictors of increased mortality (28–30). In
addition, recent data indicate that weight loss of more than 6%
(presumably non-purposeful) is associated with impaired sur-
vival (31). However, in our cohort of HF patients, in the lowest
quintiles of body composition parameters, the BMI and
percent fat measures were at levels generally considered to be
“healthy” and certainly not at levels consistent with a cachectic
state. Yet, we found the highest event rates associated with the
lowest quintiles of body composition and the lowest event rates
associated with the greater obesity. In fact, in our cohort, a
higher percent body fat was the strongest independent predic-
tor of better event-free survival—for every 1% increase in
percent body fat, clinical events fell by over 13%. Likewise, a
study by Horwich et al. (32) demonstrated that in mostly
NYHA functional class IV HF patients, various categories of
BMI were associated with similar overall survival, but like our
study, their study and a study from the Netherlands (33)
demonstrated that higher BMI was associated with better
overall survival in the multivariate analyses.
We believe that this apparent paradox in HF represents
an association and that it is unlikely that the relationship is
causal. It is recognized that peak oxygen consumption with
exercise is a potent predictor of prognosis in advanced HF.
Although, for practical purposes, fat does not consume
oxygen or receive substantial perfusion, generally cardiopul-
monary parameters are corrected for total body weight as
opposed to lean body weight (34–36). We have demon-
strated that lean adjusted exercise indices (including peak
oxygen consumption, anaerobic threshold, and oxygen-
pulse) all predict prognosis better than non-adjusted indices
(35,36), which may be particularly applicable to the favor-
able prognosis in obese HF patients with higher percent
body fat who generally have relatively high lean adjusted
exercise indices. In addition, none of the above HF studies
(27,32,33) have accounted for the effects of non-purposeful
weight loss in lean patients, which may be associated with a
more advanced form of HF.
CORONARY REVASCULARIZATION
Although obesity may also contribute to CAD risk factors
and overall prevalence of CAD, several recent studies also
point out the “obesity paradox” after revascularization pro-
cedures (37–40). In patients with CAD undergoing percu-
taneous coronary intervention (PCI), Gruberg et al. (37)
demonstrated that underweight and “normal” weight pa-
tients had worse short- and long-term outcomes compared
with overweight and obese patients. In a multivariate
analysis, higher BMI was a weak, but independent, predic-
tor of better one-year survival (37). However, in this study,
most of the excess risk seems to be attributed to the groups
with the lowest BMI (20 kg/m2, more so in those 18.5
kg/m2). Moreover, in patients who were treated with
balloon angioplasty in the Bypass Angioplasty Revascular-
ization Investigation (BARI) trial, a similar obesity paradox
was noted—every one unit increase in BMI was associated
with a 5.5% lower adjusted risk for major in-hospital events
(38). Ellis et al. (39), in a study of over 3,500 patients who
underwent PCI, demonstrated that low to normal-weight
patients (BMI 25 kg/m2) and severely obese patients
(BMI 35 kg/m2) had higher in-hospital mortality com-
pared with overweight and mildly obese patients (BMI 26 to
35 kg/m2). In a study of over 6,000 patients undergoing PCI
at the Mayo Clinic (40), obese patients had similar to lower
mortality rates compared with normal-weight patients,
whereas underweight patients had the highest mortality.
Moreover, underweight and normal-weight patients had
higher rates of femoral bleeding, hematoma, and blood loss
requiring transfusion compared with obese patients.
Considerable controversy exists regarding the effects of
obesity on prognosis after cardiac surgery, with some major
systems of classification indicating that obesity is associated
with higher perioperative morbidity and mortality (41). The
current article by Reeves et al. (42) in this issue of the
Journal also raises the idea of an apparent “obesity paradox”
early after coronary artery bypass grafting (CABG). Al-
though the authors recognize that obese patients may be less
likely to be selected for CABG and that, in general, obese
patients undergoing CABG may have less high-risk fea-
tures, particularly less severe CAD and LV dysfunction
compared with the lean patients, even when adjusting for
these confounding factors, they demonstrated that under-
weight patients had a higher risk of perioperative compli-
cations, whereas the perioperative prognosis was not ad-
versely affected by overweightness and obesity. In fact, these
patients generally had similar or even better perioperative
prognosis compared with the lean patients. Moreover, they
demonstrated that the overweight and obese patients did
not have a significant increase in postoperative chest infec-
tions, and contrary to popular belief, actually had signifi-
cantly less postoperative blood loss and need for blood
transfusions. On the other hand, recent data from the BARI
trial demonstrated that whereas in-hospital complications
were not adversely affected by obesity in the CABG pa-
tients, five-year mortality progressively increased by up to
five-fold with greater obesity (38). Whether or not obesity
directly affects prognosis in CAD is still subject to considerable
debate. However, certainly all of these data would support the
idea that obese patients should not be categorically denied or
discouraged to pursue the potential benefits of coronary revas-
cularization, both percutaneous and surgical.
Although the current paper by Reeves et al. (43) may add
fuel to the fire regarding an apparent “obesity paradox,” we
urge caution that a “risk marker” not be confused with a risk
factor. Although obesity may clearly be a risk factor for
developing CAD and HF, obesity by itself may not necessarily
expose patients with these diseases to excess short-term risk,
particularly with coronary revascularization. These facts, how-
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ever, do not discount the need for more vigorous efforts at
obesity prevention and intervention, which may go a long way
to prevent these diseases and prevent the morbid complications
recognized centuries ago by Hippocrates.
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